Dynamics of Central Remyelination and Treatment Evolution in a Model of Multiple Sclerosis with Optic Coherence Tomography

Dynamics of Central Remyelination and Treatment Evolution in a Model of Multiple Sclerosis with Optic Coherence Tomography

The need for remyelinating drugs is essential for healing disabling diseases such as multiple sclerosis (MS). One of the reasons for the lack of this class of therapies is the impossibility to monitor remyelination in vivo, which is of utmost importance to perform effective clinical trials. Here, we...

Full description

Bibliographic Details
Main Authors: Rocío Benítez-Fernández, Carolina Melero-Jerez, Carmen Gil, Enrique J. de la Rosa, Ana Martínez, Fernando de Castro
Format: Article
Language:English
Published: MDPI AG 2021-02-01
Series:International Journal of Molecular Sciences
Subjects:
optic coherence tomography
multiple sclerosis
EAE
optic nerve
demyelinating diseases
remyelinating drugs
Online Access:https://www.mdpi.com/1422-0067/22/5/2440

Internet

https://www.mdpi.com/1422-0067/22/5/2440

Similar Items